Skip to content

Clinical trials

Observational Obesity trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Observational Country / region: Australia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20101
20122
20131
20142
20182
20201
20213
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status4
Recruiting3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S3
Garvan Institute of Medical Research2
Monash University2
University of Adelaide2
Apollo Endosurgery, Inc.1
Australian Catholic University1
Children's & Women's Health Centre of British Columbia1
Murdoch Childrens Research Institute1
Pennington Biomedical Research Center1
Queensland Centre for Gynaecological Cancer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity18
Overweight3
Diabetes Mellitus, Type 22
Inflammation2
Insulin Resistance2
Body Weight1
Communicable Diseases1
Congenital Abnormalities1
Diabetes Mellitus1
Endometrial Neoplasms1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.